Effective August 2, 2022, mdxhealth has acquired the Oncotype DX GPS (Genomic Prostate Score) test from Exact Sciences. To help ensure a smooth transition for patients, continue to place orders for this test through the existing Exact Sciences portal until further notice. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the Oncotype DX GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the following press release. Questions? Email: gps@mdxhealth.com

Baltimore

Thrive, An Exact Sciences Company

Address:
1812 Ashland Avenue
Suite 640
Baltimore, MD 21205
Phone:
844-870-8870


Our Purpose

We strive to change lives through earlier, smarter answers across the cancer journey.

module-dna-icon
Our Promise

We relentlessly pursue life-changing answers in cancer that give people the clarity they need to take action, earlier.

teamwork
Our Principles
  • Earlier Answers
  • Advanced Science & Technology
  • Human Spirit
  • Visionary Collaborations
  • Rooted in Communities
icon-shield